ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 1206

$561K Total Retail Price of All Prescriptions

Rank: 110 out of 1206

439 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 9,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 590 553 1 3
SIMVASTATIN 483 462 2 1
FUROSEMIDE 450 419 3 5
LEVOTHYROXINE SODIUM 436 418 4 2
POTASSIUM CHLORIDE 361 338 5 12
AMLODIPINE BESYLATE 350 339 6 6
LISINOPRIL 223 197 7 4
METOPROLOL TARTRATE 218 217 8 9
TRIAMTERENE-HCTZ 218 190 8 33
WARFARIN SODIUM 195 187 10 8
METOPROLOL SUCCINATE 194 177 11 15
ATORVASTATIN CALCIUM 170 147 12 13
CITALOPRAM HBR 164 153 13 16
DILTIAZEM 24HR CD 136 136 14 67
CRESTOR 136 134 14 30
TRAMADOL HCL 134 95 16 17
DIOVAN 133 125 17 57
ATENOLOL 131 131 18 14
METFORMIN HCL 126 98 19 10
PREDNISONE 111 106 20 28
ALLOPURINOL 109 103 21 24
SERTRALINE HCL 104 80 22 22
BENAZEPRIL HCL 99 93 23 39
FLUTICASONE PROPIONATE 97 92 24 42
POLYETHYLENE GLYCOL 3350 91 72 25 31
CEPHALEXIN 91 87 25 62
AZITHROMYCIN 90 80 27 46
TRAZODONE HCL 89 74 28 37
NEXIUM 87 83 29 47
RANITIDINE HCL 86 74 30 23
KLOR-CON 10 77 77 31 93
HYDROCODONE-ACETAMINOPHEN 77 36 S3 31 7
EXELON 76 74 33 149
TAMSULOSIN HCL 75 75 34 26
CARVEDILOL 73 67 35 32
ALENDRONATE SODIUM 73 72 35 19
DIGOXIN 71 71 37 43
CIPROFLOXACIN HCL 71 65 37 61
CLOPIDOGREL 66 51 39 48
TRAMADOL HCL-ACETAMINOPHEN 62 57 40 243
NOVOLOG 61 46 41 100
NITROGLYCERIN PATCH 61 61 41 253
LANTUS 59 41 43 38
NAMENDA 58 40 44 36
JANTOVEN 56 44 45 95
INSULIN SYRINGE 54 36 46 111
BUMETANIDE 50 50 47 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.